Malignant brain tumour - Clinical trials 

  • Clinical trials

Clinical trials for Malignant brain tumour (cancerous)

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Malignant brain tumour (cancerous). For all clinical trials, go to clinical trials search

This list shows clinical trials for Malignant brain tumour (cancerous)

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Malignant brain tumour (cancerous)
Title Recruitment status Location
An evaluation of the tolerability and feasibility of combining 5-Amino-Levulinic Acid (5-ALA) with carmustine wafers (Gliadel) in the surgical management of primary Glioblastoma (GALA-5 Trial) Recruiting United Kingdom
Educational Follow-up in a Cohort of Children at the Royal Marsden Hospital (RMH) Recruiting United Kingdom
Phase 1 trial of olaparib with temozolomide in relapsed glioblastoma Recruiting United Kingdom
Markers of Aggressive Local Therapy In Newly diagnosed Glioblastomas Recruiting United Kingdom
Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma Not recruiting United Kingdom
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib with Lomustine to the Efficacy of Lomustine Alone - REGAL Not Recruiting United Kingdom
Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour Not recruiting United Kingdom
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib with Lomustine to the Efficacy of Lomustine Alone - REGAL Not Recruiting United Kingdom
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib with Lomustine to the Efficacy of Lomustine Alone - REGAL Authorised United Kingdom
Treatment of children aged 3 to 18 years with newly diagnosed brain tumour (known as supratentorial high-grade glioma) using bevacizumab, an anti-angiogenic drug, added to conventional therapy (surgery, chemotherapy with temozolomide and radiation therapy) Authorised United Kingdom
  • Link to Directgov – public services all in one place
  • The Information Standard - Certified member